Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.7 |
mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |